Telomir Pharmaceuticals, Inc.
TELO
$2.00
$0.042.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -87.69% | 105,408.33% | 33,284.00% | 12,803.42% | 233,778.57% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -10.73% | 8,171.43% | 7,630.00% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -44.18% | -- | -- |
| Total Current Assets | -85.98% | 204.23% | 340.96% | 2,086.99% | -- |
|
|
|||||
| Total Current Assets | -85.98% | 204.23% | 340.96% | 2,086.99% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -85.98% | -72.27% | -80.41% | -64.51% | -- |
|
|
|||||
| Total Accounts Payable | 152.21% | -16.93% | 2.12% | -53.43% | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 1,082.28% | -85.14% | -96.45% | -71.27% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 34.05% | -49.01% | -80.90% | -73.72% | -- |
|
|
|||||
| Total Current Liabilities | 34.05% | -49.01% | -80.90% | -73.72% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1,082.28% | -85.14% | -96.45% | -71.27% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 34.05% | -49.01% | -80.90% | -73.72% | -- |
|
|
|||||
| Common Stock & APIC | 39.77% | 78.49% | 306.95% | 237.46% | -- |
| Retained Earnings | -61.31% | -117.55% | -484.74% | -619.45% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -105.34% | -81.30% | -79.70% | -59.70% | 421.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -105.34% | -81.30% | -79.70% | -59.70% | 421.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -105.34% | -81.30% | -79.70% | -59.70% | 421.84% |
|
|
|||||